WXSH-0150 | m-entrepreneurship.com

Product Name :
WXSH-0150

Search keywords :
TUL01101

drugId :
null

Target Vo:
Tyrosine-protein kinase JAK1

Target Vo Short Name :
JAK1

Moa_Name:
Tyrosine-protein kinase JAK1 inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Zhuhai United Laboratories Co Ltd

Active Company_Name :
Zhuhai United Laboratories Co Ltd

Active Indication_Name:
Dermatitis, Atopic

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Phase 2 Clinical

China Highest Status:
Phase 2 Clinical

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Amatuximab supplier
ULK1 Rabbit mAb Autophagy
Caspase-12 Antibody: Caspase-12 Antibody is an unconjugated, approximately 46 kDa, rabbit-derived, anti-Caspase-12 polyclonal antibody. Caspase-12 Antibody can be used for: WB, ELISA, IHC-P, IHC-F, IF expriments in human, mouse, rat, background without labeling.

Author: Betaine hydrochloride

Related Posts